Advertisements


Roche"s Child Arthritis Drug"s New Formulation Gets FDA Nod

Zacks.....»»

Category: topSource: redinewsSep 14th, 2018

Halozyme: Roche receives approval for subcutaneous formulation of trastuzumab

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 17th, 2018

Roche CEO says Brexit, drug regulation threaten U.K. science, Reuters says

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 13th, 2018

Gilead"s Rheumatoid Arthritis Drug Successful in Phase III

Zacks.....»»

Category: topSource: redinewsSep 12th, 2018

Gilead"s Rheumatoid Arthritis Drug Successful in Phase III

Gilead (GILD) and partner Galapagos' rheumatoid arthritis candidate meets all primary and key secon.....»»

Category: worldSource: nytSep 12th, 2018

The Daily Biotech Pulse: Foamix Jumps on Data, Positive Results for Galapagos-Gilead"s Rheumatoid Arthritis Drug, Bausch Health Trims Debt

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs Sept. 11.) BioSpecifics Technologies Corp. (NASDAQ: BSTC) Genomic Heal.....»»

Category: earningsSource: benzingaSep 12th, 2018

The Daily Biotech Pulse: Foamix Jumps on Data, Positive Results for Galapagos-Gilead"s Rheumatoid Arthritis Drug, Bausch Health Trims Debt

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs Sept. 11.) read more.....»»

Category: blogSource: benzingaSep 12th, 2018

Drug succeeds in arthritis study, Gilead stock jumps

A new drug meant to help rheumatoid arthritis achieved .....»»

Category: topSource: marketwatchSep 11th, 2018

Roche faces U.K. pricing row over multiple sclerosis drug, Reuters says

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 9th, 2018

Roche faces UK pricing row over multiple sclerosis drug Ocrevus

Roche faces a fresh row over drug pricing in Britain, following a decision by the body responsible for medicine use within the state health service not to approve its drug Ocrevus for treating a highly disabling form of multiple sclerosis (MS)......»»

Category: topSource: reutersSep 9th, 2018

Biotech Analysis Central Pharma News: Novartis" Positive News, Roche Unloads Drug, Zai Lab Suffers Failure

Biotech Analysis Central Pharma News: Novartis" Positive News, Roche Unloads Drug, Zai Lab Suffers Failure.....»»

Category: topSource: seekingalphaAug 28th, 2018

AbbVie"s Imbruvica Approved for Type of Non-Hodgkin Lymphoma

FDA approves drug in combination with Roche's RituxanRelated Stocks: ABBV, XSWX:RO,.....»»

Category: blogSource: gurufocusAug 27th, 2018

Roche"s Lung Cancer Drug Alecensa Gets Approval in China

The China National Drug Administration approves Roche's (RHHBY) cancer drug Alecensa as a monotherapy for first-line treatment of advanced non-small ce.....»»

Category: smallbizSource: nytAug 20th, 2018

Roche"s (RHHBY) Xolair Gets Breakthrough Therapy Status

Genentech's, a subsidiary of Roche (RHHBY), allergy drug, Xolair, gets Breakthrough Therapy designation in the United States for the prevention of severe f.....»»

Category: dealsSource: nytAug 13th, 2018

Innovus signs purchase agreement for Apeaz arthritis drug with Showcase

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 10th, 2018

Mylan stock drops 3% after wipeout of a second quarter

Chief Executive Heather Bresch, who became the poster child for pharmaceutical villainy over EpiPen price hikes in 2016, also critiqued the U.S. drug pricing system......»»

Category: topSource: moneycentralAug 8th, 2018

Mylan stock drops 3% after wipeout of a second quarter

Chief Executive Heather Bresch, who became the poster child for pharmaceutical villainy over EpiPen price hikes in 2016, also critiqued the U.S. drug pricing system......»»

Category: topSource: marketwatchAug 8th, 2018

Roche (RHHBY) 1H18 Revenues Up Y/Y on Solid New Drug Sales

Roche's (RHHBY) performance in the first half is buoyed by solid strength in new drugs like Ocrevus. The increase in guidance is impressive as well. Swiss pharma .....»»

Category: worldSource: nytJul 27th, 2018

Roche Hiked Cancer Drug Price Before Empty Promise To Keep Flat

Swiss drugma.....»»

Category: blogSource: zerohedgeJul 21st, 2018

Roche Takes Drug-Price Posturing to New Heights

Roche Takes Drug-Price Posturing to New¬†Heights.....»»

Category: topSource: washpostJul 20th, 2018

Roche tells Dow Jones won"t raise U.S. drug prices for rest of year

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 20th, 2018